Sanders Capital LLC reduced its position in UnitedHealth Group Inc. (NYSE:UNH) by 5.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,872,433 shares of the healthcare conglomerate’s stock after selling 157,841 shares during the period. UnitedHealth Group comprises about 3.4% of Sanders Capital LLC’s portfolio, making the stock its 12th largest position. Sanders Capital LLC owned approximately 0.30% of UnitedHealth Group worth $415,119,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Columbia Partners L L C Investment Management increased its position in shares of UnitedHealth Group by 3.0% in the first quarter. Columbia Partners L L C Investment Management now owns 63,462 shares of the healthcare conglomerate’s stock worth $8,180,000 after buying an additional 1,862 shares during the last quarter. Bristlecone Advisors LLC increased its position in shares of UnitedHealth Group by 168.2% in the first quarter. Bristlecone Advisors LLC now owns 4,640 shares of the healthcare conglomerate’s stock worth $598,000 after buying an additional 2,910 shares during the last quarter. BlackRock Fund Advisors increased its position in shares of UnitedHealth Group by 1.0% in the first quarter. BlackRock Fund Advisors now owns 13,712,983 shares of the healthcare conglomerate’s stock worth $1,767,604,000 after buying an additional 135,025 shares during the last quarter. Insight Capital Research & Management Inc. purchased a new position in shares of UnitedHealth Group during the first quarter worth about $4,513,000. Finally, Clarius Group LLC increased its position in shares of UnitedHealth Group by 3.8% in the first quarter. Clarius Group LLC now owns 2,257 shares of the healthcare conglomerate’s stock worth $290,000 after buying an additional 83 shares during the last quarter. 85.78% of the stock is currently owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Inc. (NYSE:UNH) traded down 2.49% on Tuesday, reaching $134.64. 1,888,632 shares of the company’s stock were exchanged. The company has a 50 day moving average price of $137.69 and a 200-day moving average price of $136.52. The company has a market capitalization of $128.23 billion, a PE ratio of 21.07 and a beta of 0.57. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $144.48.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, beating analysts’ consensus estimates of $1.89 by $0.07. UnitedHealth Group had a return on equity of 19.08% and a net margin of 3.51%. The company earned $46.50 billion during the quarter, compared to the consensus estimate of $45.05 billion. On average, equities research analysts anticipate that UnitedHealth Group Inc. will post $7.90 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were paid a dividend of $0.625 per share. This represents a $2.50 annualized dividend and a dividend yield of 1.81%. The ex-dividend date was Tuesday, September 6th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 39.12%.

Several analysts have weighed in on UNH shares. Wedbush reissued an “outperform” rating and set a $165.00 target price on shares of UnitedHealth Group in a research report on Tuesday, July 19th. Argus raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $170.00 target price on the stock in a research report on Friday, July 22nd. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, June 21st. Citigroup Inc. boosted their target price on shares of UnitedHealth Group from $148.00 to $164.00 and gave the stock a “buy” rating in a research report on Wednesday, July 20th. Finally, Credit Suisse Group AG reissued a “buy” rating and set a $148.00 target price on shares of UnitedHealth Group in a research report on Wednesday, June 29th. One equities research analyst has rated the stock with a hold rating, twenty-five have given a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $155.35.

In other news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction on Wednesday, September 7th. The stock was sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares of the company’s stock, valued at approximately $271,100,350.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.65% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.